The ALS risk gene ataxin‐2 (ATXN2) also gives rise to antisense transcripts, ATXN2‐AS, with increased expression in ALS patient tissue (Li, Sun, et al., 2016). This evidence concerns the gene ATXN2 and amyotrophic lateral sclerosis.